Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors.

In this study, we examined the in vivo pharmacological effects of the sequential delivery of dexamethasone (DX) followed by vascular endothelial growth factor (VEGF) on the immune response and localized vascular network formation around a hydrogel-coated, micro-capillary implant for single-walled carbon nanotube based fluorescence sensors. We demonstrate, for the first time, imaging of an SWNT fluorescence device implanted subcutaneously in a rat. For tissue response studies, the chick embryo chorioallantoic membrane (CAM) was used as a tissue-model for an 8-day implantation period. The average vascular density of the tissue surrounding a hydrogel-coated microdialysis capillary sensor with simultaneous, sequential, or no delivery of DX and VEGF was 1.24+/-0.35x10(-3)vessels/microm(2), 1.15+/-0.30x10(-3)vessels/microm(2) and 0.71+/-0.20x10(-3)vessels/microm(2), respectively. Calculation of the therapeutic index (vasculature/inflammation ratio), which reflects promotion of angiogenesis versus the host immune response, demonstrates that sequential DX/VEGF delivery was 60.3% and 139.3% higher than that of VEGF and DX release alone, respectively, and was also 32.1% higher when compared to simultaneous administration, proving to be a more effective strategy in utilizing the pharmacological impact of DX and VEGF around the biosensor-model implant.

[1]  Diane J Burgess,et al.  Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[2]  D. Dorsky,et al.  Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. , 2005, Biomaterials.

[3]  F Moussy,et al.  In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. , 2002, Journal of biomedical materials research.

[4]  M. Strano,et al.  Reversible control of carbon nanotube aggregation for a glucose affinity sensor. , 2006, Angewandte Chemie.

[5]  Mark E Meyerhoff,et al.  In vivo chemical sensors: tackling biocompatibility. , 2006, Analytical chemistry.

[6]  Mark C. Hersam,et al.  Sorting carbon nanotubes by electronic structure using density differentiation , 2006, Nature nanotechnology.

[7]  D. Carbone,et al.  VEGF as a mediator of tumor-associated immunodeficiency , 2001, Immunologic research.

[8]  M. Strano,et al.  Near-infrared optical sensors based on single-walled carbon nanotubes , 2004, Nature materials.

[9]  Thomas E. Eurell,et al.  Single‐Walled Carbon Nanotube Spectroscopy in Live Cells: Towards Long‐Term Labels and Optical Sensors , 2005 .

[10]  H. Dai,et al.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Peter G Jacobs,et al.  Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. , 2004, Diabetes technology & therapeutics.

[12]  D. Delpy,et al.  Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation. , 1988, Biochimica et biophysica acta.

[13]  Michael S. Strano,et al.  Optical Detection of DNA Conformational Polymorphism on Single-Walled Carbon Nanotubes , 2006, Science.

[14]  V. C. Moore,et al.  Band Gap Fluorescence from Individual Single-Walled Carbon Nanotubes , 2002, Science.

[15]  F. Moussy,et al.  Ex ova chick chorioallantoic membrane as a novel model for evaluation of tissue responses to biomaterials and implants. , 2003, Journal of biomedical materials research. Part A.

[16]  W M Reichert,et al.  In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. , 2005, Biomaterials.

[17]  U Fischer,et al.  Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? , 1992, Journal of biomedical engineering.

[18]  J. Benda,et al.  Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices. , 2007, Biomaterials.

[19]  Jeffrey A. Hubbell,et al.  Rapid photopolymerization of immunoprotective gels in contact with cells and tissue , 1992 .

[20]  D. Dorsky,et al.  Use of vascular endothelial cell growth factor gene transfer to enhance implantable sensor function in vivo. , 2003, Journal of biomedical materials research. Part A.

[21]  P H Burri,et al.  Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti‐angiogenesis in vivo , 2001, The Anatomical record.

[22]  David C. Martin,et al.  Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. , 2006, Biomaterials.

[23]  J. Hubbell,et al.  Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials. , 1991, Biomaterials.

[24]  Y Noishiki,et al.  Tissue biocompatibility of cellulose and its derivatives. , 1989, Journal of biomedical materials research.

[25]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. , 1997, Journal of biomedical materials research.

[26]  F. Moussy,et al.  Ex ova chick chorioallantoic membrane as a novel in vivo model for testing biosensors. , 2003, Journal of biomedical materials research. Part A.

[27]  F. Coenjaerts,et al.  Dexamethasone downregulates Cryptococcus neoformans-induced vascular endothelial growth factor production: a role for corticosteroids in cryptococcal meningitis? , 2004, Journal of acquired immune deficiency syndromes.

[28]  W. Reichert,et al.  Biomaterials community examines biosensor biocompatibility. , 2000, Diabetes technology & therapeutics.

[29]  S. Lora,et al.  Covalently immobilized enzymes on biocompatible polymers for amperometric sensor applications. , 1996, Biosensors & bioelectronics.

[30]  A. Pathak,et al.  Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. , 2003, Neuro-oncology.

[31]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[32]  Michael S Strano,et al.  In vivo fluorescence detection of glucose using a single-walled carbon nanotube optical sensor: design, fluorophore properties, advantages, and disadvantages. , 2005, Analytical chemistry.

[33]  Wisniewski,et al.  Methods for reducing biosensor membrane biofouling. , 2000, Colloids and surfaces. B, Biointerfaces.

[34]  T. Chiles,et al.  Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing , 2005, Nature Methods.

[35]  N Wisniewski,et al.  Characterization of implantable biosensor membrane biofouling , 2000, Fresenius' journal of analytical chemistry.

[36]  K. Spanel‐Borowski,et al.  The chick chorioallantoic membrane as test system for biocompatible materials , 1989, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[37]  F. Moussy.  Biosensor/tissue interactions , 2000, 1st Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine and Biology. Proceedings (Cat. No.00EX451).

[38]  A Heller,et al.  Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. , 1997, Biomaterials.

[39]  F. Moussy,et al.  The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. , 2002, Journal of biomedical materials research.

[40]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. , 1998, Journal of biomedical materials research.

[41]  N. Jain,et al.  Effects of anti-inflammatory drugs on increased vascular permeability in acute inflammatory response in the chicken. , 1995, Avian pathology : journal of the W.V.P.A.

[42]  N. Wisniewski,et al.  Water-soluble treatments to enhance glucose permeability of protein-resistant polymer overlayers , 2001, Journal of biomaterials science. Polymer edition.

[43]  G. Stark,et al.  Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. , 2003, Tissue engineering.

[44]  B. Christ,et al.  In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane , 1993, Cell and Tissue Research.

[45]  J. Schultz,et al.  A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. , 2000, Analytical chemistry.

[46]  N. Wisniewski,et al.  Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. , 2001, Journal of biomedical materials research.

[47]  Michael S Strano,et al.  Detection of DNA hybridization using the near-infrared band-gap fluorescence of single-walled carbon nanotubes. , 2006, Nano letters.